A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ASC30 Injection in Participants With Obesity
Clinical trial NCT06679959 · COMPLETED
Trial details
- NCT number
- NCT06679959
- Sponsor
- Ascletis Pharma (China) Co., Limited
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-16
- Primary completion
- 2026-03-26
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.